Patients with pRBD at baseline had a greater risk of dementia compared with those with no pRBD (HR 1.785, 95% CI 1.032–3.087, p = 0.038), while adjusting for age, gender, education, age of onset, and APOE ɛ4 carriers. The gene discussed is APOE; the disease is dementia.